Using the Tayside Area Formulary (TAF)
The
Tayside Area Formulary is designed to be used in conjunction with the
British National Formulary (BNF), for this reason the sections have been
numbered in the same way to allow easy cross-reference. In general, prescribing
guidance notes follow the relevant formulary section.
With
the exception of adrenaline and noradrenaline, British Approved Names (BAN) for
drugs are being replaced by the recommended International Non-proprietary Name (rINN)
where these differ. In this edition of the guide, the former BAN of an affected
drug is printed after the new name. The
new name should now be used in preference to the former old BAN.
The
full list of substances affected can be found on the website of the Medicines
and Healthcare products Regulatory Agency (MHRA) at: www.mhra.gov.uk.
Throughout the core
formulary and accompanying prescribing guidelines, good practice points are
identified with the symbolP
Newly
licensed “black triangle” drugs are identified with the symbol
▼. Doctors and
pharmacists are asked to report all suspected reactions to these drugs (i.e. any
adverse or unexpected event that could be attributed to the drug) to the CSM.
Within core formulary sections the following symbols:
and
may prefix some medicines. These symbols identify medicines as specialist
formulary medicines and refer to the following categories:
- Hospital Only
- May be prescribed in General Practice under the direction of a Specialist
For example, ‘
’
or ‘
’
medicines on
the Cardiology Specialist list are approved for prescribing by or on the
recommendation of a cardiologist or a member of their team.
Prescribers outwith the speciality should not initiate prescribing of these specialist medicines without prior communication from the relevant specialist.
Unlicensed medicines or medicines used outwith their marketing authorisation (‘off-label’) use will be annotated in the specialist formulary lists next to the medicine name or indication. For unlicensed medicines or medicines used ‘off-label’ the quality, safety and efficacy will not have been evaluated and the risk of use rests with the prescriber. Click here for further information.
Available specialist formulary lists can be accessed either from within the section ‘Specialist formulary lists and formulary development’ on the left hand menu bar of the Formulary website, or from the Formulary ‘Appendices’ at the bottom of the left hand menu bar, alternatively, click here.
© 2010 NHS Tayside